WallStreetZenWallStreetZen

NASDAQ: CTNM
Contineum Therapeutics Inc Stock Ownership - Who owns Contineum Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Contineum Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Carmine N. StengoneCEO;Pres2026-09-082,500$1.01
$2.53kBuy
Carmine N. StengoneCEO;Pres2026-09-082,500$16.46
$41.14kSell
Carmine N. StengoneCEO;Pres2026-08-032,500$16.01
$40.03kSell
Carmine N. StengoneCEO;Pres2026-08-032,500$1.01
$2.53kBuy
Daniel S. LorrainChief Scientific Officer2026-07-0925$16.00
$400.00Sell
Daniel S. LorrainChief Scientific Officer2026-07-0925$1.01
$25.25Buy
Daniel S. LorrainChief Scientific Officer2026-07-081,015$16.00
$16.24kSell
Carmine N. StengoneCEO and President2026-07-082,500$16.00
$40.00kSell
Carmine N. StengoneCEO and President2026-07-082,500$1.01
$2.53kBuy
Daniel S. LorrainChief Scientific Officer2026-07-081,015$1.01
$1.03kBuy

1 of 6

CTNM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTNM insiders and whales buy or sell their stock.

CTNM Shareholders

What type of owners hold Contineum Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Johnson Johnson5.26%1,979,173$26.48MInsider
Versant Venture Capital VI LP1.39%523,847$7.01MInsider
Daniel S. Lorrain0.39%145,312$1.94MInsider
Carmine N. Stengone0.05%17,217$230.36kInsider
Stephen L. Huhn0.03%12,800$171.26kInsider
Tim Watkins0.02%8,961$119.90kInsider
Montanova Capital LLC0.01%2,841$38.01kInstitution
Suvret0.01%2,841$38.01kInstitution
Juptop0.01%2,735$36.59kInstitution
Jupiter Topco LLC0.01%2,734$36.58kInstitution

1 of 3

CTNM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTNM0.08%7.14%Net SellingNet Buying
OCGN0.04%10.35%Net SellingNet Selling
INDP0.00%74.86%Net Buying
BNTC0.10%8.39%Net Buying
TTRX0.00%58.04%Net Buying
View Top Biotech Stocks

Contineum Therapeutics Stock Ownership FAQ

Who owns Contineum Therapeutics?

Contineum Therapeutics (NASDAQ: CTNM) is owned by 0.08% institutional shareholders, 7.14% Contineum Therapeutics insiders, and 92.78% retail investors. Johnson Johnson is the largest individual Contineum Therapeutics shareholder, owning 1.98M shares representing 5.26% of the company. Johnson Johnson's Contineum Therapeutics shares are currently valued at $16.95M.

If you're new to stock investing, here's how to buy Contineum Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.